Published in PLoS One on February 26, 2014
Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr Top Microbiol Immunol (2015) 1.02
Influenza virus antigenicity and broadly neutralizing epitopes. Curr Opin Virol (2015) 0.79
The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin. Acta Naturae (2016) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature (1992) 36.50
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Characterization of the 1918 influenza virus polymerase genes. Nature (2005) 15.73
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13
Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med (2002) 11.85
Main-chain bond lengths and bond angles in protein structures. J Mol Biol (1993) 9.80
Viral membrane fusion. Nat Struct Mol Biol (2008) 8.54
Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science (2011) 7.86
Global epidemiology of influenza: past and present. Annu Rev Med (2000) 7.80
A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol (1993) 6.26
Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science (2010) 6.10
A highly conserved neutralizing epitope on group 2 influenza A viruses. Science (2011) 5.66
Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology (1999) 5.07
Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes. Virology (1996) 4.04
Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum. Cell (1995) 3.80
Folding, trimerization, and transport are sequential events in the biogenesis of influenza virus hemagglutinin. Cell (1988) 3.73
Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data. Am J Epidemiol (2005) 3.58
Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J Cell Biol (1986) 3.56
Historical perspective--Emergence of influenza A (H1N1) viruses. N Engl J Med (2009) 3.53
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A (2011) 3.51
Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27
Influenza B virus in seals. Science (2000) 2.70
Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem (2010) 2.65
Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol (2007) 2.39
The contents of the syringe. Nature (2008) 2.14
The effect of universal influenza immunization on mortality and health care use. PLoS Med (2008) 2.01
Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities. Proc Natl Acad Sci U S A (2013) 1.44
Influenza M2 proton channels. Biochim Biophys Acta (2010) 1.09
Foldon-guided self-assembly of ultra-stable protein fibers. Protein Sci (2008) 0.94
Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus. PLoS One (2011) 0.90
Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes. PLoS One (2010) 0.90
Insight into structural diversity of influenza virus haemagglutinin. J Gen Virol (2013) 0.86
Evaluation of the subtype specificity of monoclonal antibodies raised against H1 and H3 subtypes of human influenza A virus hemagglutinins. J Clin Microbiol (2002) 0.85